Over the past decades, there has been a significant increase in prescriptions of psychotropic drugs for mental disorders. So far, most of the explanations of the phenomenon have focused on the process of medicalization, but little attention has been cast towards physicians’ day-to-day clinical reasoning, and the way it affects therapeutic decision-making. This article addresses the complex relationship between aetiology, diagnosis and drug treatment by examining the style of reasoning underlying prescribing practices through an historical lens. A genealogy of contemporary prescribing practices is proposed, that draws significant comparisons between 19th-century medicine and modern psychiatry. Tensions between specific, standardized cures and specific, idiosyncratic patients have been historically at play in clinical reasoning – and still are today. This inquiry into the epistemological foundations of contemporary drug prescription reveals an underlying search for scientific legitimacy.
AckerknechtEH (1973) Therapeutics from the Primitives to the Twentieth Century. New York: Harper.
2.
American Psychiatric Association (1968) Diagnostic and Statistical Manual of Mental Disorders (DSM-II). Washington: American Psychiatric Association.
3.
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (DSM-III). Washington: American Psychiatric Association.
4.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). Washington: American Psychiatric Association.
5.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington: American Psychiatric Association.
6.
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington: American Psychiatric Association.
7.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Washington: American Psychiatric Association.
AttfieldJ (1889) Chemistry: General, Medical and Pharmaceutical. The Chemistry of the US Pharmacopeia. 12th ed. Philadelphia: Lea Brothers & Co.
11.
BhataraVFeilMHoagwoodK. (2004) National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge. Journal of Attention Disorders7: 217–226.
12.
BleakleyAFarrowRGouldD. (2003) Making sense of clinical reasoning: Judgement and the evidence of the senses. Medical Education37: 544–552.
13.
BrackenPThomasPTimimiS. (2012) Psychiatry beyond the current paradigm. The British Journal of Psychiatry201(6): 430–434.
14.
BradleyCP (1992) Uncomfortable prescribing decisions: A critical incident study. British Medical Journal304(6822): 294–296.
15.
BrownP (1987) Diagnostic conflict and contradiction in psychiatry. Journal of Health and Social Behavior28: 37–50.
16.
BynumWF (1994) Science and the Practice of Medicine in the Nineteenth Century. Cambridge and New York: Cambridge University Press.
17.
ChamakB (2006) Les logiques de prescription dans le cas de l’autisme. In: CollinJOteroMMonnaisL (eds) Le médicament au cœur de la socialité contemporaine. Regards croisés sur un objet complexe. Collection Problèmes Sociaux Intervention Sociale. Sainte-Foy, QC, Canada: Presses de l’Université du Québec, pp. 253–270.
18.
CollinJ (1999) Entre discours et pratiques: les médecins montréalais face à la thérapeutique, 1869–1890. Revue d’histoire de l’Amérique française53(1): 61-92.
19.
CollinJDamestoyNLalandeR (1999) La construction d’une rationalité: les médecins et la prescription de médicaments psychotropes. Sciences sociales et santé17(2): 31-53.
20.
ConnorDF (2002) Aggression and Antisocial Behavior in Children and Adolescents: Research and Treatment. New York: Guilford Press.
21.
ConradP (2013) Medicalization: Changing contours, characteristics, and contexts. In: CockerhamWC (ed.) Medical Sociology on the Move. New York: Springer, pp. 195–214.
22.
DesrosiersHE (1886) Quelques notions générales de thérapeutique. Les maladies et les malades. La médication rationnelle et la médication empirique. Union Médicale du Canada15: 336–343.
23.
DesrosiersHE (1887) Revue trimestrielle de thérapeutique et de matière médicale. Union Médicale du Canada16: 225–231.
24.
DickinsonRHouseAODimriV. (2010) Long-term prescribing of antidepressants in the older population: A qualitative study. The British Journal of General Practice60(573): e144–e155.
25.
FoucaultM (1971) L’ordre du discours: leçon inaugurale au Collège de France prononcée le 2 décembre 1970. Paris: Gallimard.
26.
FoucaultM (2003) L’ordre du discours. Paris: Gallimard.
27.
FrancesA (2013) Saving Normal: An Insider’s Revolt against Out-of-Control Psychiatric Diagnosis, DSM-V, Big Pharma, and the Medicalization of Ordinary Life. New York: HarperCollins.
28.
GrobGNHorwitzAV (2009) Diagnosis, Therapy, and Evidence: Conundrums in Modern American Medicine. New Brunswick, NJ: Rutgers University Press.
29.
HackingI (1992) “Style” for Historians and Philosophers. Studies in the History and Philosophy of Science23(1): 1–20.
30.
HaxaireC (2006) Entre le psy et l’assistante sociale. Où mène la prescription d’antidépresseurs quand la souffrance se fait sociale. In: CollinJOteroMMonnaisL (eds) Le médicament au cœur de la socialité contemporaine. Regards croisés sur un objet complexe. Collection Problèmes Sociaux Intervention Sociale. Sainte-Foy, QC, Canada: Presses de l’Université du Québec, pp. 199–222.
31.
HealyD (2004) Let Them Eat Prozac: The Unhealthy Relationship Between he Pharmaceutical Industry and Depression. New York and London: NY University Press.
32.
HoblynJNodaaYesavageJA. (2006) Factors in choosing atypical antipsychotics: Toward understanding the bases of physicians’ prescribing decisions. Journal of Psychiatric Research40: 160–166.
33.
HorwitzAVWakefieldJC (2007) The Loss of Sadness: How Psychiatry Transformed Normal Sorrow into Depressive Disorder. Cambridge and New York: Oxford University Press.
34.
HydeJCalnanMPriorL. (2005) A qualitative study exploring how GPs decide to prescribe antidepressants. The British Journal of General Practice55(519): 755–762.
35.
JensenPSBhataraVSVitielloB. (1999) Psychoactive medication prescribing practices for US children: Gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry38(5): 557–565.
36.
JutelA (2011) Putting a Name to It: Diagnosis in Contemporary Society. Baltimore, MD: The Johns Hopkins University Press.
37.
KutchinsHKirkSA (1997) Making us Crazy: DSM: The Psychiatric Bible and the Creation of Mental Disorders. New York: Free Press.
38.
LachapelleS (1878) Quelques considérations sur la thérapeutique au sujet de la médication alcoolique dans la pneumonie. Union Médicale du Canada17: 246–247.
39.
LachapelleS (1880) Quelques erreurs en thérapeutique. Union Médicale du Canada9: 241–244.
40.
LafortuneDCollinJ (2006) La prescription de médicaments psychotropes aux enfants et adolescents: prévalence, politiques, pratiques et pistes de recherche. Canadian Psychology47: 155–169.
41.
LamarcheA (1880) Origines de la médecine et préjugés populaires. Union Médicale du Canada19: 289–304.
42.
MacdonaldSMorrisonJMaxwellM. (2009) ‘A coal face option’: GPs’ perspectives on the rise in antidepressant prescribing. The British Journal of General Practice59(566): e299–e307.
43.
McPhersonSArmstrongD (2009) Negotiating ‘Depression’ in primary care: A qualitative study. Social Science & Medicine69: 1137–1143.
44.
MatanovicSMVlahovic-PalcevskiV (2012) Potentially inappropriate medication in the elderly: A comprehensive protocol. European Journal of Clinical Pharmacology68: 1123–1138.
45.
MercierAAuger-AubinILebeauJP. (2011) Understanding the prescription of antidepressants: A qualitative study among French GPs. BMC Family Practice12: 99.
46.
MercierAAuger-AubinILebeauJP. (2013) Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: An analysis of guidelines and systematic reviews. BMC Family Practice14: 55.
47.
MiddletonHMoncrieffJ (2011) ‘They won’t do any harm and might do some good’: Time to think again on the use of antidepressants?The British Journal of General Practice61(582): 47–49.
48.
MitchellAJVazeARaoS (2009) Clinical diagnosis of depression in primary care: A meta-analysis. The Lancet374: 609–619.
49.
MojtabaiROlfsonM (2010) National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry67(1): 26–36.
50.
MoncrieffJ (1999) An investigation into the precedents of modern drug treatment in psychiatry. History of Psychiatry10(40 Pt 4): 475–490.
51.
MoncrieffJ (2008) The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment. Basingstoke: Palgrave Macmillan.
52.
MoscropA (2012) An end to depression in primary care?The British Journal of General Practice62(602): e656–e658.
53.
OlfsonM. (2012) National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Archives of General Psychiatry69(12): 1247–1256.
54.
OlfsonMMarcusSC (2009) National patterns in antidepressant medication treatment. Archives of General Psychiatry66(8): 848–856.
55.
PellegrinoED (1979) Sociocultural impact of modern therapeutics. In: VogelMRosenbergCE (eds) The Therapeutic Revolution: Essays in the Social History of American Medicine. Philadelphia, PA: University of Pennsylvania Press, pp. 245–268.
56.
RosenbergCE (1979) The therapeutic revolution: Medicine, meaning and social change. In: VogelMRosenbergCE (eds) The Therapeutic Revolution: Essays in the Social History of American Medicine. Philadelphia, PA: University of Pennsylvania Press, pp. 3–26.
57.
RosenbergCE (2007) Our Present Complaint. American Medicine Then and Now. Baltimore: The Johns Hopkins University Press.
58.
SaferDJZitoJMDosReisS (2003) Concomitant psychotropic medication for youths. The American Journal of Psychiatry160(3): 438–449.
59.
ShorterE (1997) A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. New York: John Wiley & Sons.
60.
SiriwardenaAN (2010) Why do GPs prescribe psychotropic drugs when they would rather provide alternative psychological interventions?The British Journal of General Practice60(573): 241–242.
61.
TamblynR (2004) Improving patient safety through computerized drug management: The devil is in the details. HealthcarePapers5(3): 52–68; discussion 82–84.
62.
TaylorD (2010) Antipsychotic polypharmacy – Confusion reigns. The Psychiatrist34(2): 41–43.
63.
WarnerJH (1986) The Therapeutic Perspective: Medical Practice, Knowledge, and Identity in America, 1820–1885. Cambridge, MA: Harvard University Press.
64.
WhooleyOHorwitzAV (2013) The paradox of professional success: Grand ambition, furious resistance, and the derailment of the DSM-5 revision process. In: ParisJPhilipsJ (eds) Making the DSM-5. New York: Springer, pp. 75–92.
65.
WilliamsSMartinPGabeJ (2011) The Pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness33(5): 710–725.
66.
ZitoJMSaferDJdos ReisS. (2003) Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics & Adolescent Medicine157(1): 17–25.
